Crédit Industriel et Commercial’s Moderna MRNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.95M Hold
85,000
0.38% 60
2026
Q1
$4.32M Buy
85,000
+60,000
+240% +$2.8M 0.34% 80
2025
Q4
$737K Buy
+25,000
New +$679K 0.06% 246

Other funds holding MRNA

Crédit Industriel et Commercial's MRNA Position: Q2 2026 in Review

Crédit Industriel et Commercial reduced its Moderna (MRNA) stake by 53% in Q2 2026, selling an estimated $657K and leaving 11,348 shares worth $795K. The position accounts for 0.05% of the portfolio, ranked #220.

Crédit Industriel et Commercial first reported a position in MRNA in Q4 2025 and has held it in 3 quarters since. The position peaked at $1.22M in Q1 2026. 437 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

  • Crédit Industriel et Commercial held 11,348 shares of Moderna worth $795K as of Q2 2026.
  • Crédit Industriel et Commercial sold 12,690 Moderna shares in Q2 2026, an estimated $657K.
  • Moderna made up 0.05% of Crédit Industriel et Commercial's portfolio in Q2 2026, its #220 holding.
  • Crédit Industriel et Commercial first reported a position in Moderna in Q4 2025 and has held it in 3 quarters since.
  • Crédit Industriel et Commercial's Moderna position peaked at $1.22M in Q1 2026.
  • 437 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on Crédit Industriel et Commercial's 13F filing for Q2 2026, filed 24 Jul 2026.